Lecrolyn Sine (Sodium Cromoglicate)

Sodium cromoglicate stabilises mast cells on the ocular surface, preventing calcium‑dependent degranulation. This blocks the release of histamine, prostaglandins and other inflammatory mediators, thereby reducing vasodilation, itching and redness associated with allergic eye reactions.

The dosing regimen for Lecrolyn Sine is determined by the prescribing clinician based on the severity of the allergic eye condition, patient age and response to therapy. The prescriber will provide specific instructions on the number of drops and frequency of administration.

Safety data for sodium cromoglicate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare professional.

To order Lecrolyn Sine, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lecrolyn Sine contains sodium cromoglicate, a mast cell stabiliser, whereas many alternative eye drops use antihistamines or non‑steroidal anti‑inflammatory agents. Sodium cromoglicate works upstream by preventing mediator release, offering a different safety profile and may be preferred when a non‑sedating, locally acting option is desired.

Lecrolyn Sine should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from direct light and moisture, and keep the cap tightly closed when not in use to maintain product stability.

The product is supplied as sterile eye drops. The patient should wash hands, tilt the head back, pull down the lower eyelid, and instill the prescribed number of drops into the conjunctival sac. The eyes should be closed gently for a few seconds to allow absorption.

Serious but rare risks include allergic contact dermatitis of the eyelid, severe ocular inflammation, vision loss, and systemic hypersensitivity reactions. Patients should seek immediate medical attention if they experience significant swelling, pain, visual changes or systemic allergic symptoms.

Lecrolyn Sine is contraindicated in individuals with a known hypersensitivity to sodium cromoglicate or any of the formulation excipients. It should also be avoided in patients with active ocular infections until the infection is adequately treated.